The British Journal of Longevity Medicine (BJLM), BILM’s open-access, peer-reviewed journal, is pleased to announce that it has secured funding to waive article processing charges (APCs) for eligible medical students enrolled at UK medical schools.

This initiative supports BJLM’s commitment to advancing the science, clinical practice and professional standards of longevity medicine, preventive medicine and regenerative health. It will give future doctors a more accessible route to publish high-quality work, engage critically with this developing discipline and contribute to a stronger evidence base for clinical practice.

An opportunity to publish

For many medical students, a first peer-reviewed publication can be an important step in developing academic confidence, research communication skills and a professional portfolio. Students submitting suitable work to BJLM will have the opportunity to:

• Publish in a peer-reviewed, open-access journal.
• Develop experience in academic writing, evidence appraisal and scientific communication.
• Build a stronger CV and portfolio for future academic and clinical opportunities.
• Share original ideas and evidence-informed perspectives on longevity medicine.
• Be entered into consideration for a £250 prize for the best student article submission.

Eligibility and submission

The APC waiver is available to medical students studying at UK medical schools. To be eligible, students should submit their manuscript using their university academic email address. Information about the initiative will be circulated to medical schools throughout the United Kingdom.

All manuscripts must follow the BJLM submission guidelines and will be considered through the journal’s standard editorial and peer-review process. Submission of an article does not guarantee publication; authors remain responsible for ensuring that their work meets the journal’s requirements for quality, format, authorship, references, declarations of interest and ethical standards where applicable. BJLM publishes work including original research, reviews, clinical perspectives, consensus statements, service evaluations and educational articles relevant to longevity medicine.

Supporting the next generation

Longevity medicine is rapidly evolving, and BJLM exists to help strengthen the quality of evidence informing practice, policy and future research. By supporting medical students to publish, this funding will encourage early engagement with rigorous, evidence-based longevity medicine and help develop the clinicians, researchers and leaders who will shape the field in the years ahead.

Eligible students are encouraged to read the BJLM submission guidelines and submit their work using their university academic email address to receive the APC waiver.